Development of a cross protective vaccine against papillomavirus infection based on the minor structural protein L2

Ähnliche Einträge

• Development of a cross-protective L2-based vaccine against oncogenic human papillomaviruses
  von: Seitz, Hanna
  Veröffentlicht: (2013)
• Development of a cross-protective L2-based vaccine against bovine papillomavirus and assessment of its safety and immunogenicity in cattle
  von: Müller, Lis
  Veröffentlicht: (2014)
• Minor capsid protein L2 polytope induces broad protection against oncogenic and mucosal Human Papillomaviruses
  von: Pouyanfard, Somayeh, et al.
  Veröffentlicht: (2018)
• Development of vaccine against human papillomavirus types 3, 10 and 77
  von: Yin, Qian
  Veröffentlicht: (2008)
• Re-engineering a nanoparticle human papillomavirus prophylactic vaccine antigen based on the minor capsid protein L2
  von: Yang, Fan
  Veröffentlicht: (2019)